1)国立研究開発法人 国立がん研究センター 社会と健康研究センター検診研究部 検診評価研究室:科学的根拠に基づくがん検診推進のページ. canscreen.ncc.go.jp
2)Sackett DL : Bias in analytic research. J Chronic Dis 32(1・2) : 51-63, 1979. PMID 447779
3)Everett SM, et al : Early gastric cancer ; disease or pseudo-disease? Lancet 351(9112) : 1350-1352, 1998. PMID 9643813
4)Torre LA, et al : Global cancer statistics, 2012. CA Cancer J Clin 65(2) : 87-108, 2015. PMID 25651787
5)Jahn JL, et al : The high prevalence of undiagnosed prostate cancer at autopsy ; implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era. Int J Cancer 137(12) : 2795-2802, 2015. PMID 25557753
6)National Cancer Institute : Cancer Stat Facts ; Prostate Cancer. https://seer.cancer.gov/statfacts/html/prost.html
7)Andriole GL, et al : Mortality results from a randomized prostate-cancer screening trial. N Engl J Med 360(13) : 1310-1319, 2009. PMID 19297565
8)Schröder FH, et al : Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360(13) : 1320-1328, 2009. PMID 19297566
9)Turner EL, et al : Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer(CAP). Br J Cancer 110(12) : 2829-2836, 2014. PMID 24867688
10)US Preventive Services Task Force, et al : Screening for prostate cancer ; US Preventive Services Task Force recommendation statement. JAMA 319(18) : 1901-1913, 2018. PMID 29801017
11)Qaseem A, et al : Screening for prostate cancer ; a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 158(10) : 761-769, 2013. PMID 23567643
12)日本泌尿器科学会(編):前立腺がん検診ガイドライン2018年版.メディカルレビュー社,2018.